ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

CUSIP: N71542109

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
+146,080
Put/Call ratio
56%
SEC-reported price per share
$1.82
Number of holders
45
Value change
+$264,549
Number of buys
12
Open additional details 1 more signal available
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
141,139,908

Security key

N71542109

Report period

Q3 2024

Institutions

45

Top holders

10

Ownership snapshot

Top reported holders of PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Privium Fund Management B.V.
Disclosed value leader
Privium Fund Management B.V.
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F Highest disclosed value: $9,208,196 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Privium Fund Management B.V. has the largest disclosed position value at $9.21M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Privium Fund Management B.V.'s linked filing trail.
Disclosed position value Top 5
Privium Fund Management B.V. $9.21M
ADAGE CAPITAL PARTNERS GP, L.L.C. $6.02M
EcoR1 Capital, LLC $3.39M
M28 Capital Management LP $1.69M
DAFNA Capital Management LLC $1.5M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Privium Fund Management B.V.
13F
Company
13F
—
denominator unverified
$9,208,196
5,580,725 shares
— 30 Jun 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$6,018,275
3,625,467 shares
— 30 Jun 2024
EcoR1 Capital, LLC
13F
Company
13F
—
denominator unverified
$3,391,000
2,042,771 shares
— 30 Jun 2024
M28 Capital Management LP
13F
Company
13F
—
denominator unverified
$1,692,367
1,019,498 shares
— 30 Jun 2024
DAFNA Capital Management LLC
13F
Company
13F
—
denominator unverified
$1,503,266
905,582 shares
— 30 Jun 2024
Ghost Tree Capital, LLC
13F
Company
13F
—
denominator unverified
$1,494,000
900,000 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
45
Shares
17,443,866
Rows available
45
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
47
Q3 2024 holders
45
Holder diff
-2
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .